Osteopontin Promoter Polymorphisms are Associated With Susceptibility to Gastric Cancer

    loading  Checking for direct PDF access through Ovid



To evaluate the significance of osteopontin (OPN) genotypes in the susceptibility to gastric cancer.


The expression of OPN has been correlated with development, invasiveness, metastasis, and survival of gastric cancer, but the role of polymorphisms in the OPN promoter has not been investigated.


We enrolled 146 gastric cancer patients and 128 controls. DNA was extracted from peripheral blood leucocytes. Single-nucleotide polymorphisms (SNPs) in the OPN promoter (−66, −156, −443, −616, −1748, and −1776) were analyzed by pyrosequencing and direct sequencing methods. Logistic regression analyses were used to evaluate the associations between SNPs and development of gastric cancer.


SNP −443 C/C and −616 T/T of the OPN promoter were significantly associated with gastric cancer [odds ratio (OR)=2.88; 95% confidence interval (CI), 1.16-7.12 and OR=1.95; 95% CI, 1.35-2.82, respectively]. Analysis of the combined effect of OPN promoter SNPs revealed that the combination of SNP −443 (T/C or C/C) and SNP −616 (T/T or T/G) had the most significant association with gastric cancer (OR=3.95; 95% CI, 1.58-9.90).


Our results suggest that polymorphisms in the OPN promoter are associated with the development of gastric cancer, and the combination of SNP −443 (T/C or C/C) and −616 (T/T or T/G) most significantly increases susceptibility to gastric cancer.

Related Topics

    loading  Loading Related Articles